Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIC vs Bevacizumab + Chemotherapy in BRAF V600E-mutated Advanced Colorectal Cancer
NCT05540951Phase 3Unknown
- Sponsor
- Fudan University
- Start
- Jun 2018
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vemurafenib in colorectal cancer (CRC), sponsored by Fudan University. Status: unknown.
02
Drugs
vemurafenib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05540951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05540951.